Perspectives of The Pharmacological Modulation of Ca2+/ Camp Signaling Interaction as a New Neuroprotector Therapeutic Strategy for Amyotrophic Lateral Sclerosis (ALS)

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease characterised by progressive muscular paralysis reflecting selective degeneration and death of motor neurons in the primary motor cortex, brainstem and spinal cord. Several evidences suggest the involvement of the imbalance of the intracellular Ca2+ homeostasis in the death of motor neurons in ALS. It is now recognized that the interaction between intracellular signaling pathways mediated by Ca2+ and cAMP (Ca2+/cAMP signalling interaction) plays as a key role in several cellular processes of mammalians, including neurotransmission and neuroprotection. Our previous studies have indicated that the pharmacological modulation of the Ca2+/cAMP signalling interaction by the combined use of the Ca2+ channel blockers (CCBs) and drugs that increment of the intracellular concentration of cAMP (cAMP-enhancer compounds) can increase neurotransmission, and stimulate neuroprotective response in neurodegenerative diseases. We have proposed that the pharmacological modulation of Ca2+/cAMP signalling interaction could open a new avenue for the drug development more effective and safer for treating neurodegenerative diseases, including ALS. In this review article, we discuss the perspectives of the pharmacological modulation of the Ca2+/ cAMP signalling interaction as a new therapeutic strategy for ALS.

Authors and Affiliations

Afonso Caricati-Neto, Leandro Bueno Bergantin

Keywords

Related Articles

Severe Single Dose Methotrexate Neurological Toxicity after Treatment for Ectopic Pregnancy: A Case Report

Severe methotrexate neurological adverse event due to medical treatment of an ectopic pregnancy is presented. Severe adverse effects are rare among patiens treated for ectopic pregnancy with MTX. , it should be used with...

Implications for the Inclusion of Echo Intensity for Athlete Monitoring: A Mini Review

Ultrasound measurements have been used extensively throughout the literature as a reliable and valid method for examining muscle structure. More recently, ultrasound imaging has been used to guide the training process an...

Hypertrophic Cardiomyopathy....in Search of its Own Identity

Hypertrophic cardiomyopathy is a disease of muscle of heart. The incidence is 0.2% in general population. Only 15% of total patients are being diagnosed and large no of patients are yet to be screen-p...

Flapless Dental Implant: Contemporary Trends in Literature Coverage

The past decade in medicine it has been established the concept of minimally invasive surgery, consisting in taking advantage of advancements experienced in diagnostic techniques and specific surgical instruments, to per...

Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient’s Satisfaction in Saudi Arabia

Introduction: Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors is the newest class of oral hypoglycemic agents that was approved for the management of patients with T2DM. Gliflozin group (Empagliflozin, Dapagliflozin &...

Download PDF file
  • EP ID EP567234
  • DOI 10.26717/BJSTR.2017.01.000131
  • Views 140
  • Downloads 0

How To Cite

Afonso Caricati-Neto, Leandro Bueno Bergantin (2017). Perspectives of The Pharmacological Modulation of Ca2+/ Camp Signaling Interaction as a New Neuroprotector Therapeutic Strategy for Amyotrophic Lateral Sclerosis (ALS). Biomedical Journal of Scientific & Technical Research (BJSTR), 1(1), 117-121. https://europub.co.uk/articles/-A-567234